Elevated plasma levels of soluble tumor necrosis factor receptor (sTNFRp60) reflect severity of acute pancreatitis

Intensive Care Medicine

Volumn 23, Issue 8, 1997, Pages 841-848

  Kaufmann, P ^a   Tilz, G P ^a   Lueger, A ^a   Demel, U ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Acute pancreatitis; Acute Physiology and Chronic Health Evaluation score III (APACHE III); Soluble tumor necrosis factor receptor (sTNFR)

Indexed keywords

C REACTIVE PROTEIN; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ACUTE HEMORRHAGIC PANCREATITIS; ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LEUKOCYTE; MALE; MULTIPLE ORGAN FAILURE; PREDICTION;

ACUTE DISEASE; ANALYSIS OF VARIANCE; AUSTRIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PANCREATITIS; PANCREATITIS, ACUTE NECROTIZING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 0030780056     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050420     Document Type: Article

References (36)

1. Tracey KJ, Lowry SF (1990) Role of cytokine mediators in septic shock. Adv Surg 23: 21-56
2. Exley AR, Leese T, Holliday MP, Swann RA, Cohen J (1992) Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut 33: 1126-1128
3. Wardle N (1991) Tumour necrosis factor and its control. Clin Intensive Care 2: 282-287
4. Collery MP, Kamei T, Mangiro MJ, Flye W (1991) Organ interactions in sepsis. Arch Surg 126: 28-31
5. Goris RJA (1990) Mediators of multiple organ failure. Intensive Care Med 16: S192-S196
6. Akira S, Hirano T, Taga T, Kishimoto T (1990) Biology of multifunctional cytokines. FASEB J 4: 2860-2867
7. Engelberts I, Stephens S, Francot GJ et al (1991) Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet 338: 515-516
8. Lantz M, Malik S, Slevin ML et al (1990) Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokine 2: 402-406
9. Spinas GA, Keller U, Brockhaus M (1992) Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J Clin Invest 90: 533-536
10. Brouckaert P, Libert C, Everaerdt B, Takahashi N, Cauwels A, Fiers W (1993) Tumor necrosis factor, its receptors and the connection with interleukin 1 and inlerleukin 6. Immunobiology 187: 317-329
11. Froon AHM, Bemelmans HA, Greve JW, van der Linden CJ, Buurman WA (1994) Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome: correlation with plasma creatinine values. Crit Care Med 22: 803-809
12. Godfried MH, van-der-Poll T, Jansen J, Romijn JA, Schattenkerk JK, Endert E, van-Deventer SJ, Sauerwein HB (1993) Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection. AIDS 7: 33-36
13. Foley N, Lambert C, McNichol M, Johnson R, Rook G (1990) An inhibitor of the toxicity of TNF in the serum of patients with sarcoidosis, tuberculosis and Crohn's disease. Clin Exp Immunol 80: 395-399
14. Steinberg W, Tenner S (1994) Acute pancreatitis. N Engl J Med 330: 1198-1210
15. Uhl W, Büchler M, Malfertheiner P, Martini M, Beger HG (1991) PMN-elastase in comparison with CRP, anti-proteases and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 6: 253-259
16. Leser HG, Gross V, Scheibenbogen C, Heinisch A, Salm R, Lausen M, Rückauer K, Andreesen R, Farthmann EH, Schölmerich J (1991) Elevation of interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 191: 782-785
17. Rinderknecht H (1988) Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol 3: 105-112
18. Ventrucci M, Pezzilli R, Gullo L, Plate L, Sprovieri G, Barbara L (1989) Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease. Dig Dis Sci 34: 39-45
19. Freeny PC (1991) Angio-CT: diagnosis and detection of complications of acute pancreatitis. Hepatogastroenterology 38: 109-115
20. Wagner DP, Knaus WA, Harrell FE, Zimmerman JE, Watts C (1994) Daily prognostic estimates for critically ill adults in intensive care units: results from a prospective, multicenter, inception cohort analysis. Crit Care Med 22: 1359-1372
21. Ranson HC, Pasternack BS (1977) Statistical methods for quantifying the severity of clinical acute pancreatitis. J Surg Res 22: 77-79
22. Zimmerman JE, Wagner DP, Draper EA, Knaus WA (1994) Improving intensive care unit discharge decisions: supplementing physician judgment with predictions of next day risk for life support. Crit Care Med 22: 1373-1384
23. Kaufmann P, Hofmann G, Smolle KH, Lueger A, Pieber T, Brunner G, Krejs GJ (1996) Intensive care management of acute pancreatitis: recognition of patients at high risk of developing severe or fatal complications. Wien Klin Wochenschr 108: 9-15
24. Adolf GR, Apfler I (1991) A monoclonal antibody-based enzyme immunoassay for quantitation of human tumor necrosis factor binding protein I, a soluble fragment of the 60 kDa TNF receptor in biological fluids. J Immunol Meth 143: 127-136
25. Junge W, Troge B, Klein G, Poppe W, Gerber M (1989) Evaluation of a new assay for pancreatic amylase: performance characteristics and estimation of reference intervals. Clin Biochem 22: 109-114
26. Ziegenhorn J, Neumann U, Knitsch RW, Zwez W (1979) Determination of serum lipase. Clin Chem 25: 1067-1070
27. Borque de Larrea L, Rus A, Carlström A, Pira U, Delobbes E, Thiry P, Ferrari L, Barozzi D, Hafner G, Lotz J, van Oers RJM, Leerkes B, Szymanowicz A, Dubois H, Hallstein A, Domke I (1993) Determination of C-reactive protein by an improved turbidimetric assay on Boehringer Mannheim/ Hitachi analysis systems. Klin Lab 39: 55-62
28. Wilson C, Heads A, Shenkin A, Imrie CW (1989) C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg 76: 177-181
29. Lantz M, Malik S, Slevin ML et al (1990) Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokine 2: 402-406
30. Spinas GA, Keller U, Brockhaus M (1992) Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J Clin Invest 90: 533-536
31. van Zee KJ, Kohno T, Fischer E et al (1992) Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor-alpha in vitro and in vivo. Proc Natl Acad Sci USA 89: 4845-4849
32. Brockhaus M, Bar-Khayim Y, Gurwicz S et al (1992) Plasma tumor necrosis factor soluble receptors in chronic renal failure. Kidney Int 42: 663-667
33. Froon AHM, Bmelmans MHA. Greve JW. van der Linden CJ, Buurman WA (1994) Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome: correlation with plasma creatinine values. Crit Care Med 22: 803-809
34. Larvin M, McMahon MJ (1989) APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet 2: 201-204
35. Debets JM, Kampmeijer R, Van der Linden MP, Buurman WA, Van der Linden CJ (1989) Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med 17: 489-494
36. Luscinskas FW, Cyhulsky MI, Kiely J-M, Peckins CS, Davis VM, Gimbrone MA Jr (1991) Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1. J Immunol 146: 1617